Compare Diastika Biotekindo Tbk. (CHEK) vs Charlie Hospital Semarang Tbk. (RSCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diastika Biotekindo Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Diastika Biotekindo Tbk. trades at Rp126 (market cap 514.17B, 1.22M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is the larger of the two by market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 1.22M). Which is the better fit depends on your goals.
| CHEK | RSCH | |
|---|---|---|
Market Cap | 514.17B | 715.5B |
Volume | 1.22M | 30.64M |
Lot | 12.25K | 306.41K |
Turnover | 155.6M | 7.98B |
Average Price | 127.05 | 260.34 |
Value | 155.6M | 7.98B |
Indicative Equilibrium Price | 126 | 256 |
Indicative Equilibrium Volume | 503 | 512 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diastika Biotekindo Tbk.
PT Diastika Biotekindo Tbk. (The Company) was established in Jakarta based on Deed No. 33 dated July 20, 1989 made before Mrs. Sitti Marjami Soepangat, SH. notary in Jakarta. The Company started its commercial activities in years 1986. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on CHEK →About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →
